This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Elvira Munguira: A Pioneer in Antiparasitic Innovations
Introduction: Elvira Munguira, based in Madrid, Spain, is a prominent inventor recognized for her contributions to the field of microbiology and pharmacology. She has successfully secured a patent for her innovative work on anthelmintic milbemycin analogs derived from novel microorganisms. Her research holds significant potential in developing effective agents for combating parasitic infections.
Latest Patents: Elvira's patent, titled "Anthelmintic milbemycin analogs of novel microorganisms," details a series of macrolides isolated from the fermentation broth of specific microorganisms identified as MA-6825, MA-6864, and MA-6865. The patent showcases the structural characteristics of these novel compounds based on extensive analytical studies. These compounds demonstrate high potency as antiparasitic, insecticidal, and anthelmintic agents, positioning them among the important class of macrolides known as milbemycins. Additionally, the patent includes formulations for potential applications of these compounds.
Career Highlights: Elvira Munguira is associated with Merck & Company, Inc., a leading global healthcare firm known for its focus on innovative research and development. Her work has contributed significantly to Merck's portfolio in the area of antiparasitic treatments, showcasing her expertise and commitment to advancing medical science.
Collaborations: Throughout her career, Elvira has collaborated with notable colleagues such as Robert T Goegelman and Maria T Diez Matas. These partnerships have enhanced her research's impact, enabling the exchange of ideas and fostering an environment of innovation.
Conclusion: Elvira Munguira stands out as a dedicated inventor with a focus on developing powerful antiparasitic agents through her groundbreaking research. Her patent not only highlights her innovative capabilities but also her role in advancing healthcare solutions that can benefit many. With her position at Merck & Company, Inc., Elvira continues to contribute to the field, driving advancements that can significantly influence public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile